{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-005068","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2024-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.137778+00:00","generated_at":"2026-06-06T22:53:41.847818+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Orthofix appoints Julie Andrews as CFO with inducement stock awards and severance agreement","bullets":["Julie Andrews started as CFO on Jan 15, 2024; previously CFO at Smart Wires and SVP Finance at Wright Medical.","Received inducement grants: performance-based RSUs for 65,934 shares (at target), time-based RSUs for 32,967 shares, and options for 76,878 shares.","Severance equal to 1.0x base salary + target bonus (1.5x on change in control) plus COBRA reimbursement for up to 12 months.","Options vest when service conditions met and stock price averages 150% of grant date price over one month.","Interim CFO Geoffrey Gillespie thanked; company expects Andrews to help drive growth and shareholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-005068","json":"https://secwatch.observer/filing/0000950170-24-005068.json","markdown":"https://secwatch.observer/filing/0000950170-24-005068.md","text":"https://secwatch.observer/filing/0000950170-24-005068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/0000950170-24-005068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/ofix-20240115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T22:53:41.847818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9a5d31033b","claim":"Julie Andrews was appointed as Chief Financial Officer at Orthofix Medical Inc..","evidence_excerpt":"On January 15, 2024, Julie Andrews began service as Chief Financial Officer of Orthofix Medical Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024005068/0000950170-24-005068-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"began service"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}